Compare TERN & BKV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TERN | BKV |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | 2021 | 2024 |
| Metric | TERN | BKV |
|---|---|---|
| Price | $27.52 | $28.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 7 |
| Target Price | $25.59 | ★ $29.86 |
| AVG Volume (30 Days) | ★ 5.6M | 843.5K |
| Earning Date | 11-10-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.53 |
| Revenue | N/A | ★ $822,525,000.00 |
| Revenue This Year | N/A | $47.77 |
| Revenue Next Year | N/A | $22.22 |
| P/E Ratio | ★ N/A | $53.72 |
| Revenue Growth | N/A | ★ 33.41 |
| 52 Week Low | $1.87 | $15.00 |
| 52 Week High | $29.51 | $28.67 |
| Indicator | TERN | BKV |
|---|---|---|
| Relative Strength Index (RSI) | 74.11 | 66.87 |
| Support Level | $25.31 | $24.98 |
| Resistance Level | $29.51 | $26.95 |
| Average True Range (ATR) | 1.95 | 1.24 |
| MACD | 0.08 | 0.02 |
| Stochastic Oscillator | 81.51 | 90.31 |
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
BKV Corp is a growth-driven energy company. Its core business is production of natural gas from its owned and operated upstream businesses. It operates in four business lines: natural gas production, natural gas gathering, processing and transportation (natural gas midstream business), power generation and carbon capture, utilization, and sequestration (CCUS).